EGFR抑制剂在非小细胞肺癌中的应用(5)
[10] Martinez E, Martinez M, Vin Olas N, et al. Feasibility and tolerability of the addition of erlotinib to 3D thoracic radiotherapy (RT) in patients (p) with unresectable NSCLC: a prospective randomized phase II study[J]. J Clin Oncol. 2008, 26: abstr 7563.[11] Kelly K, Chansky K ......
您现在查看是摘要页,全文长 2548 字符。